Down Expression of FBP1 Is a Negative Prognostic Factor for Non–Small-Cell Lung Cancer
- 6 April 2015
- journal article
- research article
- Published by Informa UK Limited in Cancer Investigation
- Vol. 33 (5), 197-204
- https://doi.org/10.3109/07357907.2015.1020385
Abstract
Downregulation of fructose-1,6-bisphosphatse-1 (FBP1) was observed in several cancers but its role in the lung cancer still remains unknown. We examined the cancer tissues from 140 patients with nonsmall cell lung cancer patients and found that the relative gene expression of FBP1 was significantly lower in lung cancer tissues as compared to incisal marginal tissues and normal tissues. The patients with higher level of FBP1 RNA expression have significantly longer disease free survival and overall survival as compared to the lower expression groups. There was a negative correlation with the level of FBP1 and recurrence of the lung cancer.Keywords
This publication has 20 references indexed in Scilit:
- Personalized Cancer Medicine: Molecular Diagnostics, Predictive biomarkers, and Drug ResistanceCancer Cell, 2012
- Promoter Hypermethylation Mediated Downregulation of FBP1 in Human Hepatocellular Carcinoma and Colon CancerPLOS ONE, 2011
- Aberrant methylation of human L- and M-fructose 1,6-bisphosphatase genes in cancerBiochemical and Biophysical Research Communications, 2008
- Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and SurvivorshipMayo Clinic Proceedings, 2008
- Identification of the transforming EML4–ALK fusion gene in non-small-cell lung cancerNature, 2007
- EGF receptor gene mutations are common in lung cancers from “never smokers” and are associated with sensitivity of tumors to gefitinib and erlotinibProceedings of the National Academy of Sciences of the United States of America, 2004
- EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib TherapyScience, 2004
- Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to GefitinibNew England Journal of Medicine, 2004
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- On the Origin of Cancer CellsScience, 1956